Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP23113.RAcmWhmJuKIK_ADJdv3AEddEmEQsX6eO94Nsi-JzPeS0w130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23113.RAcmWhmJuKIK_ADJdv3AEddEmEQsX6eO94Nsi-JzPeS0w130_provenance.
• NP23115.RAScNQ562MlcIfvPlmwZ1r6kSkRN0sEwWO4198prSFgAE130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23115.RAScNQ562MlcIfvPlmwZ1r6kSkRN0sEwWO4198prSFgAE130_provenance.
• NP91262.RAT1XieWFSM8RwWvMn1DYlcJyPFYumoyFnb49dPJRn0I0130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91262.RAT1XieWFSM8RwWvMn1DYlcJyPFYumoyFnb49dPJRn0I0130_provenance.
• NP91417.RAQAkWN1ps3vTEMLxU9KgmNH-5HHiQN4JWDDCtpXhL_-0130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91417.RAQAkWN1ps3vTEMLxU9KgmNH-5HHiQN4JWDDCtpXhL_-0130_provenance.
• NP91774.RATA6-ZTGlxIgu46jW5z7qgcSj3P8GSJc5cNO_LvAiTHY130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91774.RATA6-ZTGlxIgu46jW5z7qgcSj3P8GSJc5cNO_LvAiTHY130_provenance.
• NP91852.RAYZwwJAtW3J5l-Dep3S5lX3GBL7B9j3sz8HC5zFsC3iI130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91852.RAYZwwJAtW3J5l-Dep3S5lX3GBL7B9j3sz8HC5zFsC3iI130_provenance.
• NP124932.RAfesq-NpdWelI_quTyoHTBPvRTCZrH7T2ZJXkGkqRxJU130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP124932.RAfesq-NpdWelI_quTyoHTBPvRTCZrH7T2ZJXkGkqRxJU130_provenance.
• NP126606.RAQiSVKBukpiotOADuVBU0P6QGwTq59u1TtlWo8y1dgmc130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP126606.RAQiSVKBukpiotOADuVBU0P6QGwTq59u1TtlWo8y1dgmc130_provenance.
• NP126607.RAd8cJjBloDCk9sVqmbLFCZw9-EM1ip-vKQn0XvygG92w130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP126607.RAd8cJjBloDCk9sVqmbLFCZw9-EM1ip-vKQn0XvygG92w130_provenance.
• NP126608.RAdaEUfIkGfjtJ9ELbc6EKknKyn-zqvf3wAm7Lp2uuTuE130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP126608.RAdaEUfIkGfjtJ9ELbc6EKknKyn-zqvf3wAm7Lp2uuTuE130_provenance.
• NP23008.RAzkmrNp36icX7SvIJDonbg3KWyxl-SWKODO_WU9Xox8w130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23008.RAzkmrNp36icX7SvIJDonbg3KWyxl-SWKODO_WU9Xox8w130_provenance.
• NP23114.RA1s_LCSBwNewSEGc3bpnmLHzg6-CGxx4lYJsajOlcylk130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23114.RA1s_LCSBwNewSEGc3bpnmLHzg6-CGxx4lYJsajOlcylk130_provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP23016.RAo7Oc9MKBgcUuOFbwmNtyUKeqS4-EUqOaxaXJwIRcKII130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23016.RAo7Oc9MKBgcUuOFbwmNtyUKeqS4-EUqOaxaXJwIRcKII130_provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP139354.RAfggwBcLmBeuea8jhRC8rmW42n7OAi9CHeLHssroOzK4130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139354.RAfggwBcLmBeuea8jhRC8rmW42n7OAi9CHeLHssroOzK4130_provenance.
• NP139355.RAU9U0agZB0P8fs2bZtuFfEWezxoMkFVjKmHZzbWRnOcI130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139355.RAU9U0agZB0P8fs2bZtuFfEWezxoMkFVjKmHZzbWRnOcI130_provenance.
• NP139356.RASJa-yrSzVteDMjRL-dQti85ZaEh1flY_Foevogly64k130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139356.RASJa-yrSzVteDMjRL-dQti85ZaEh1flY_Foevogly64k130_provenance.
• NP139357.RAUlvMJjNMpv9uA1NEW99wmKMw2DpIobD-KGf4S68xw5A130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139357.RAUlvMJjNMpv9uA1NEW99wmKMw2DpIobD-KGf4S68xw5A130_provenance.
• NP139361.RAa6cvsHoheHTB_PkDZlRwLWOkeJqXxQgFFoVyW4_mSxs130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139361.RAa6cvsHoheHTB_PkDZlRwLWOkeJqXxQgFFoVyW4_mSxs130_provenance.
• NP139369.RAY8PYaJnXn5HhGkn7DhPNRuJZ7LT7LGNfiqHfYdkf5Bc130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139369.RAY8PYaJnXn5HhGkn7DhPNRuJZ7LT7LGNfiqHfYdkf5Bc130_provenance.
• NP139371.RAdEGHYiG-SuYEPhyxSyokCGwdiJspniAeYzq1nrh4NZQ130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139371.RAdEGHYiG-SuYEPhyxSyokCGwdiJspniAeYzq1nrh4NZQ130_provenance.
• NP91260.RAllbWh2UGHKG3xypAKAEhZZN25yUyFBl8qLf64L8UQpU130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91260.RAllbWh2UGHKG3xypAKAEhZZN25yUyFBl8qLf64L8UQpU130_provenance.
• NP91261.RAqBx9nhc1snko3MwGjdJef7dibyUrPa-IKUBIVk-zAeU130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91261.RAqBx9nhc1snko3MwGjdJef7dibyUrPa-IKUBIVk-zAeU130_provenance.
• NP124933.RAuAkO-KigAgdRpVbdcqbGu_N2H6Nkjze9lkGSybKt8Hg130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP124933.RAuAkO-KigAgdRpVbdcqbGu_N2H6Nkjze9lkGSybKt8Hg130_provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP23308.RAplsbSJi9JAdQnrKCJXKtIotBfA2BGfDpuYQqAUHOTsk130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23308.RAplsbSJi9JAdQnrKCJXKtIotBfA2BGfDpuYQqAUHOTsk130_provenance.
• NP23313.RAqVhJyTMl_2JoV0igm7fY4KbqKabnYkwKMyqi2AIoO30130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23313.RAqVhJyTMl_2JoV0igm7fY4KbqKabnYkwKMyqi2AIoO30130_provenance.
• NP139359.RArgmLjTgvupq80a933YypGaK-ncFY9fBrJyGsddoThjA130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139359.RArgmLjTgvupq80a933YypGaK-ncFY9fBrJyGsddoThjA130_provenance.
• NP139364.RAgr4MkqYJy9o65xSBuXewmFWXXK1PuizPUaTByJaMk30130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139364.RAgr4MkqYJy9o65xSBuXewmFWXXK1PuizPUaTByJaMk30130_provenance.
• NP139365.RApxFD58qZ_uUv5Ce-lzqWmvWmKpVCFKlA3B9JghNEC9M130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139365.RApxFD58qZ_uUv5Ce-lzqWmvWmKpVCFKlA3B9JghNEC9M130_provenance.
• NP139367.RAgAkuxL8uZWPmbzQfJRZQBR3M10FgSSHm_0Uip5TLdpw130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139367.RAgAkuxL8uZWPmbzQfJRZQBR3M10FgSSHm_0Uip5TLdpw130_provenance.
• NP139372.RAr0V7im5v7tbEXF5YFmnetdKhFOTBTVn2Blm26oDHbEc130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139372.RAr0V7im5v7tbEXF5YFmnetdKhFOTBTVn2Blm26oDHbEc130_provenance.
• NP139374.RAhZmF-hl7ctXimamqvYXXCiaJMSTWfCXeoiTu1GgJHwQ130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139374.RAhZmF-hl7ctXimamqvYXXCiaJMSTWfCXeoiTu1GgJHwQ130_provenance.
• NP91259.RAHkV8C5QoB-irNzzVRDs5L5rJfH4KSj7qx6EvxNOSgJY130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91259.RAHkV8C5QoB-irNzzVRDs5L5rJfH4KSj7qx6EvxNOSgJY130_provenance.
• NP91464.RA-bIiG_41rJAkPAd_-V3v8he5nbaKDYEhCAlwjXn2WvU130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91464.RA-bIiG_41rJAkPAd_-V3v8he5nbaKDYEhCAlwjXn2WvU130_provenance.
• NP120568.RAF4UbjKZm4KkiKJHOo43wki21W_Rri9FfYDiJEwzpgHs130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120568.RAF4UbjKZm4KkiKJHOo43wki21W_Rri9FfYDiJEwzpgHs130_provenance.
• NP120541.RA9S7c4HGkQ1xMUkngCMHj4iBD1uA3-396P9aZllZz_nc130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120541.RA9S7c4HGkQ1xMUkngCMHj4iBD1uA3-396P9aZllZz_nc130_provenance.
• NP120569.RA3EJ-kNUaE0HFSUuQ5OWD8GLlc3-pPzjs6BwcaHjvdGg130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120569.RA3EJ-kNUaE0HFSUuQ5OWD8GLlc3-pPzjs6BwcaHjvdGg130_provenance.
• NP120570.RA4kyAhFHdMCDE0kmttr_-ZsL0w117lz19Cxy1l4LFEEM130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120570.RA4kyAhFHdMCDE0kmttr_-ZsL0w117lz19Cxy1l4LFEEM130_provenance.
• NP124934.RA71uw9O4yPn_XXop1FzdEpLpCnHuhSJNq-X_kOhcG2B0130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP124934.RA71uw9O4yPn_XXop1FzdEpLpCnHuhSJNq-X_kOhcG2B0130_provenance.
• NP124931.RANoaq--XVnzYlz0F4P_47gfx9HXTk1ZJe_TiMK5QX0LA130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP124931.RANoaq--XVnzYlz0F4P_47gfx9HXTk1ZJe_TiMK5QX0LA130_provenance.
• NP126604.RAG7dVY3BYABTTjTtjEf7sbBuXPv_UtbeLyAy26Nkme0g130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP126604.RAG7dVY3BYABTTjTtjEf7sbBuXPv_UtbeLyAy26Nkme0g130_provenance.
• NP353632.RAz9zaihFFru2qFosD_3zar-6xriZC1rrtv_Uwt8YbRas130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353632.RAz9zaihFFru2qFosD_3zar-6xriZC1rrtv_Uwt8YbRas130_provenance.
• NP23310.RAECbw_9zl5JWqlnSRsK3uAeeAcohQhGjCERu4gL3cKsc130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23310.RAECbw_9zl5JWqlnSRsK3uAeeAcohQhGjCERu4gL3cKsc130_provenance.
• NP23314.RAGzhFgEcUVY2-DJsPWJQwmhZtfsDwzEc0DJsqM40yZ-M130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23314.RAGzhFgEcUVY2-DJsPWJQwmhZtfsDwzEc0DJsqM40yZ-M130_provenance.
• NP23315.RAFmSLrj2S5P8bsALSsw-5Fwxch2Yo0MjmVGaFNaHQxVI130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23315.RAFmSLrj2S5P8bsALSsw-5Fwxch2Yo0MjmVGaFNaHQxVI130_provenance.
• NP139363.RAN64GzFnw8WvlNM0fzM9_hbhHtBca2WBqAWa2Itu3qDE130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139363.RAN64GzFnw8WvlNM0fzM9_hbhHtBca2WBqAWa2Itu3qDE130_provenance.
• NP139366.RAJE-tCN7WDR2cd4deiXKOrNmfrFtwosaC7aMwDWkhung130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139366.RAJE-tCN7WDR2cd4deiXKOrNmfrFtwosaC7aMwDWkhung130_provenance.
• NP715869.RAKrfSNUaJLxKf6i1WAaNSUNL0i0sQyF3yEgQ9E0gFtyo130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715869.RAKrfSNUaJLxKf6i1WAaNSUNL0i0sQyF3yEgQ9E0gFtyo130_provenance.
• NP23309.RAybhpPEyAbWevQqGneHqoNnKhiodJJxSvH_9ghDaHTG0130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23309.RAybhpPEyAbWevQqGneHqoNnKhiodJJxSvH_9ghDaHTG0130_provenance.
• NP23311.RA8AlCv6HrXOcrCMFRZ4LTQ3b-8bF_GgIzCy6x7YSv9v0130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23311.RA8AlCv6HrXOcrCMFRZ4LTQ3b-8bF_GgIzCy6x7YSv9v0130_provenance.
• NP23312.RA4U_m6gv3mBM41EEoQ9HRvZGnPqttrCN_f3wI2Q4-L8E130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23312.RA4U_m6gv3mBM41EEoQ9HRvZGnPqttrCN_f3wI2Q4-L8E130_provenance.
• NP139351.RA7X4BxhRrZw0ChzsPToJGzT8FJI1QD_e0FNORTo5mzfE130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139351.RA7X4BxhRrZw0ChzsPToJGzT8FJI1QD_e0FNORTo5mzfE130_provenance.
• NP139360.RA5ioIZ1k8dhaInTkxwiRczHRKw8GAbnXMy5b3SwRrhyM130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139360.RA5ioIZ1k8dhaInTkxwiRczHRKw8GAbnXMy5b3SwRrhyM130_provenance.
• NP139362.RA1y-_QIYRYveU8eFPF9tRr-XvZikWunKeZOAbLMpVIMs130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139362.RA1y-_QIYRYveU8eFPF9tRr-XvZikWunKeZOAbLMpVIMs130_provenance.
• NP139368.RA50NIYkyGVI2kMLlqo7HVyIXsYSfreX5ARmRJC2vM4js130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139368.RA50NIYkyGVI2kMLlqo7HVyIXsYSfreX5ARmRJC2vM4js130_provenance.
• NP139373.RA6aBhRyIF2-bfiCiD4gZgYtWM-8sZ6muQqZ8SlonzuFY130_assertion description "[Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139373.RA6aBhRyIF2-bfiCiD4gZgYtWM-8sZ6muQqZ8SlonzuFY130_provenance.